Evidence map›Paper›PMID 23853213›Full record

SynthesisGut2014

Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.

Hashem B El-Serag, Stephen Sweet, Christopher C Winchester, John Dent

11 registry-linked trialsAbstract readSystematic Review
In one paragraph

Synthesis in Gut, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 11 registered trials, which are not on this map. Cited by 837 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
837citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02464930 unknown statusnot on this mapstarted 2015, after this paper: background citation

Evaluation of MicroRNA Expression in Blood and Cytology Specimens as a Novel Method for Detecting Barrett's Esophagus

TypeobservationalSponsorMidwest Biomedical ResearchRan2015 to 2018Enrolled220ConditionsBarrett's Esophagus, Gastroesophageal Reflux, Esophageal Adenocarcinoma
NCT02959424 completednot on this mapstarted 2016, after this paper: background citation

Quality of Life Among Patients With Chronic Esophageal Disorders : Spanish Translation and Validation of the Survey "Northwestern Esophageal Quality of Life Scale" in Hispanics

TypeobservationalSponsorCarlos Robles-MedrandaRan2016 to 2017Enrolled385ConditionsGastroesophageal Reflux Disease and Esophageal Motility DisordersArmsSpanish Northwestern Esophageal Quality of Life questionnaire
NCT04130659 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Open, Comparative Study To Evaluate The Performance And Safety Of The Medical Device Marial® In Association With Proton-Pump Inhibitors Versus PPI Alone In Patients Affected By Gastroesophageal Reflux Disease

TypeinterventionalSponsorNekkar Lab SrlRan2019 to 2025Enrolled110ConditionsGastroesophageal Reflux Disease (GERD)ArmsMARIAL® + PPI (generic Omeprazole), PPI alone (generic omeprazole), MARIAL® alone
NCT04293965 phase1completednot on this mapstarted 2018, after this paper: background citation

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose and Multiple-dose X842 in Healthy Subjects.

TypeinterventionalSponsorJiangsu Sinorda Biomedicine Co., LtdRan2018 to 2019Enrolled80ConditionsHealthy VolunteersArmsSingle ascending dose of X842, Multiple ascending dose of X842, Food Effect
NCT05050188 phase1completednot on this mapstarted 2021, after this paper: background citation

A Phase I, Randomized, Double-blind, Placebo- and Positive-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of H008 (Carenoprazan Hydrochloride Tablets) in Healthy Volunteers

TypeinterventionalSponsorJiangsu Carephar Pharmaceutical Co., Ltd.Ran2021 to 2021Enrolled24ConditionsErosive EsophagitisArmsH008, H008 placebo, Lansoprazole
NCT05283447 nacompletednot on this mapstarted 2022, after this paper: background citation

Effectiveness of Manual Therapy in the Treatment of Gastroesophageal Reflux Disease in Patients With Type I Hiatal Hernia

TypeinterventionalSponsorEscoles Universitaries GimbernatRan2022 to 2023Enrolled44ConditionsGastroesophageal RefluxArmsOsteopathic Medicine, Control
NCT05353933 nacompletednot on this mapstarted 2022, after this paper: background citation

Efficacy and Safety of Thread Embedding Acupuncture Combined With PPI in Treating GERD

TypeinterventionalSponsorUniversity of Medicine and Pharmacy at Ho Chi Minh CityRan2022 to 2022Enrolled66ConditionsGastroesophageal RefluxArmsThread embedding acupuncture, Pantoprazole 40mg
NCT05570448 narecruitingnot on this mapstarted 2022, after this paper: background citation

Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)

TypeinterventionalSponsorMidwest Veterans' Biomedical Research FoundationRan2022 to 2027Enrolled36ConditionsGastro Esophageal RefluxArmsARAT, Sham intervention (control)
NCT05579587 withdrawnnot on this mapstarted 2024, after this paper: background citation

Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients

TypeobservationalSponsorBrigham and Women's HospitalRan2024 to 2025Enrolled0ConditionsGastroesophageal Reflux Disease (GERD), Laryngopharyngeal Reflux (LPR), Reflux Disease, Gastro-Esophageal, Motility DisorderArmsTransoral Incisionless Fundoplication
NCT06157424 nacompletednot on this mapstarted 2023, after this paper: background citation

Evaluating Efficacy and Safety of Combined Thread Embedding and Auricular Acupuncture in Gastroesophageal Reflux Disease With Liver Qi Invading Stomach Pattern: A Randomized Controlled Trial

TypeinterventionalSponsorUniversity of Medicine and Pharmacy at Ho Chi Minh CityRan2023 to 2024Enrolled66ConditionsGERDArmsThread Embedding Acupuncture, Auricular acupuncture, Standard treatment
NCT06928350 recruitingnot on this mapstarted 2025, after this paper: background citation

Normal Values of Ambulatory 24-hour Oesophageal pH-impedance Monitoring in an Indian Cohort of Participants

TypeobservationalSponsorAsian Institute of Gastroenterology, IndiaRan2025 to 2026Enrolled50ConditionsGERD (Gastroesophageal Reflux Disease)
3 · Its place in the literature

Who cites it

837 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Article

777 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hashem B El-SeragSection of Gastroenterology and Hepatology, Houston Veterans Affairs Medical Center (152), , Houston, Texas, USA.
Stephen Sweet
Christopher C Winchester
John Dent

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Hashem B El-Serag · 2001 to 2026
$28.3M
Research Training in GastroenterologyT32DK083266 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Hashem B El-Serag, FASIHA KANWAL · 2010 to 2026
$2.3M
Epidemiology and Outcomes of Digestive and Liver Diseases: A Mentoring ProgramK24DK078154 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI EL-SERAG, HASHEM B · 2007 to 2016
$1.1M
12TH CONFERENCE ON HEMOGLOBIN SWITCHINGR13DK058338 · NIDDK · UNIVERSITY OF WASHINGTON · PI STAMATOYANNOPOULOS, GEORGE · 2000 to 2000
$45k
NIDDK NIH HHS DK58338NIDDK NIH HHS K24 DK078154NIDDK NIH HHS P30 DK056338NIDDK NIH HHS T32 DK083266PHS HHS K24-04-107
6 · The paper itself

Abstract

objectiveTo update the findings of the 2005 systematic review of population-based studies assessing the epidemiology of gastro-oesophageal reflux disease (GERD).

designPubMed and Embase were screened for new references using the original search strings. Studies were required to be population-based, to include ≥ 200 individuals, to have response rates ≥ 50% and recall periods <12 months. GERD was defined as heartburn and/or regurgitation on at least 1 day a week, or according to the Montreal definition, or diagnosed by a clinician. Temporal and geographic trends in disease prevalence were examined using a Poisson regression model.

results16 studies of GERD epidemiology published since the original review were found to be suitable for inclusion (15 reporting prevalence and one reporting incidence), and were added to the 13 prevalence and two incidence studies found previously. The range of GERD prevalence estimates was 18.1%-27.8% in North America, 8.8%-25.9% in Europe, 2.5%-7.8% in East Asia, 8.7%-33.1% in the Middle East, 11.6% in Australia and 23.0% in South America. Incidence per 1000 person-years was approximately 5 in the overall UK and US populations, and 0.84 in paediatric patients aged 1-17 years in the UK. Evidence suggests an increase in GERD prevalence since 1995 (p<0.0001), particularly in North America and East Asia.

conclusionsGERD is prevalent worldwide, and disease burden may be increasing. Prevalence estimates show considerable geographic variation, but only East Asia shows estimates consistently lower than 10%.

Indexed as

AsiaAustraliaEuropeGastroesophageal RefluxHumansIncidenceMiddle EastNorth AmericaPrevalenceSouth AmericaEpidemiologyGastroesophageal Reflux Disease

Identifiers

PMID23853213
PMCPMC4046948

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

and 5 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.